Kirt, Anila and Zhao, Jingjun (2017) A New Era In Treatment Of Malignant Melanoma: Biological therapies. Journal of Biomedicine and Health, 2 (1). pp. 1-8.
Full text not available from this repository.Abstract
Even though melanoma skin cancers represent few cases (less than 5 of all skin cancer cases), their overall mortality rate is strikingly higher, i.e., accounts for about 60-80 of deaths. The reason is that treatment of the malignant form of this disease has always been a therapeutic challenge. Until 2011, the favored therapeutic approaches for advanced melanoma included interleukin-2 Â and nonspecific alkylating agents and/or antineoplastic agents. However, these traditional treatment approaches have always shown a grimmer prognosis due to their relatively low survival benefit and toxicity. Over the past decades, with the better understanding and study of the effect of immunological approaches in the development of melanoma, treatment approaches have undergone changes. Accordingly, various institutions for biological modalities have shown some improvement in the treatment scenario of malignant melanoma. As a result, in this review, we discussed newer novel therapeutic agents and summarized the outcomes from recent major clinical trials.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Saeed Shoja |
| Date Deposited: | 18 Feb 2018 09:29 |
| Last Modified: | 18 Feb 2018 09:29 |
| URI: | http://eprints.medsab.ac.ir/id/eprint/40 |
Actions (login required)
 |
View Item |
